R ecent studies have revealed that few elderly patients receive chemotherapy for advanced non-small cell lung cancer (NSCLC), even though it has been shown that the majority of patients will benefit from systemic treatment. The authors of the current study hypothesized that this may be occurring in the general population of patients with NSCLC, not just the elderly. To investigate, researchers conducted a largescale, retrospective, population-based study of patients diagnosed with stage IV NSCLC, examining practice patterns in relation to systemic treatment and changes in chemotherapy administration over time, as well as associations with survival (Cancer [published online ahead of print April 17, 2015]. doi: 10.1002/cncr.29386).

中文翻译：

---

所有年龄的晚期非小细胞肺癌患者均未接受化疗

最近的研究表明，很少有老年患者接受晚期非小细胞肺癌 (NSCLC) 的化疗，尽管已经表明大多数患者将从全身治疗中受益。当前研究的作者假设这可能发生在 NSCLC 患者的一般人群中，而不仅仅是老年人。为了进行调查，研究人员对诊断为 IV 期 NSCLC 的患者进行了一项大规模、回顾性、基于人群的研究，检查与全身治疗相关的实践模式和化疗给药随时间的变化，以及与生存的关联（癌症 [提前在线发布] 2015 年 4 月 17 日印刷]。doi：10.1002/cncr.29386）。